Safe Orthopaedics announces the signature of an agreement with Brainlab for the development of navigation for Safe Orthopaedics instruments
21 Februar 2022 - 5:45PM
Safe Orthopaedics announces the signature of an agreement with
Brainlab for the development of navigation for Safe Orthopaedics
instruments
Safe Orthopaedics announces the signature of an
agreement with Brainlab for the development of navigation for Safe
Orthopaedics instruments
- Making Safe Orthopaedics instruments navigable with the
Brainlab ecosystem
- Making minimally invasive surgery safe
|
|
|
|
Éragny-sur-Oise, February 21, 2022 at
5:45 p.m. CET - Safe (FR0013467123 - ALSAF), a company
specializing in the design, manufacture and marketing of
ready-to-use technologies for back surgery, particularly for the
safe treatment of emergency vertebral fractures, announces the
signature of a development agreement with Brainlab to make Safe
Orthopaedics' instruments navigable.
Brainlab is a world leader in medical
navigation, particularly for spine surgery. Brainlab spinal
navigation allows for precise positioning of pedicle screws and a
considerable reduction in X-ray exposure. This technology allows
for more precise planning of incisions and trajectories with any
instrument and assists in implant positioning, especially in
anatomically critical areas for mini-invasive surgery. Because it
requires fewer verification images regarding precise instrument
tracking, Brainlab spinal navigation provides less X-ray exposure
for the surgical team and the patient.
The planned collaboration between the two
companies consists in making Safe Orthopaedics' off-the-shelf
technologies compatible with Brainlab's 3D spine and trauma
navigation technology.
Navigated surgery is highly precise and requires
robust associated instrumentation that does not tolerate any
mechanical play that would impair surgical precision. This is why
Safe Orthopaedics instruments, always new and always sterile, will
bring an additional degree of precision and reliability to the
surgeon during navigated surgery.
"Safe's strategy of collaboration with leading
players such as Brainlab will enable us to leverage the impact of
our technology and consolidate our position as the leader in
ready-to-use devices. The compatibility of SteriSpinePS 2nd
generation, initiated more than a year ago, with Brainlab
navigation will allow us to secure the mini-invasive act and a
quick recovery of the patient" comments Thomas Droulout,
Technical Director and co-founder of Safe Orthopaedics.
"This new surgical technique is now used by several hundred
hospitals worldwide, mainly in Europe and the United States,
confirming the trend towards conversion of the global market. In
addition to recently announced products such as Hickory and
Sycamore, which will have a lasting impact on Safe Orthopaedics'
growth, we are preparing for future growth drivers with this
partnership.
About Safe groupSafe group is a
French medical technology group that brings together Safe
Orthopaedics, a pioneer in ready-to-use technologies for spinal
column pathologies, and Safe Medical (formerly LCI Medical), a
subcontractor of medical devices for orthopedic surgery. The group
employs approximately 150 people.
Safe Orthopaedics develops and manufactures kits
combining sterile implants and single-use instruments, available at
any time to the surgeon. These technologies are part of a minimally
invasive approach aimed at reducing the risk of contamination and
infection, for the benefit of the patient and with a positive
impact on hospitalization times and costs. Protected by 18
patent families, SteriSpineTM kits are CE marked and FDA approved.
Safe Orthopaedics is headquartered in the Paris region (95610
Eragny-sur-Oise) and has subsidiaries in the United Kingdom,
Germany, the United States and the Lyon region
(Fleurieux-sur-l'Arbresle).
For more information:
www.safeorthopaedics.com
Safe Medical produces implantable medical
devices and ready-to-use instruments. It has an innovation center
and two production sites in France (Fleurieux-sur-l'Arbresle,
69210) and in Tunisia, offering numerous industrial services:
design, industrialization, machining, finishing and sterile
packaging. Supported by the French stimulus plan in 2020, the
companý is investing in additive printing and will be operational
in 2022 on this new technology.
For more information: www.safemedical.fr
Contacts
Safe
Group
François-Henri Reynaud
Chief Financial and Administrative Officer
Tél. : +33 (0)1 34 21 50
00
investors@safeorthopaedics.com
Press RelationsUlysse
CommunicationPierre-Louis Germain / +33 (0)6 64 79
97 51 / plgermain@ulysse-communication.com
Bruno Arabian / +33 (0)6 87 88 47 26 /
barabian@ulysse-communication.com
SAFE (EU:ALSAF)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
SAFE (EU:ALSAF)
Historical Stock Chart
Von Jul 2023 bis Jul 2024